# Darktrace Holdings Startup profile on Capital Atlas: https://capitalatlas.ai/startups/darktrace-holdings - Industry: IT Security/Cybersecurity - Headquarters: Cambridge, UK - Website: www.darktrace.com - Total disclosed funding: $158M - Latest round: Series E (Oct 4, 2018) - Investors on record: 8 ## About Founded in 2013 by Dave Palmer, Emily Orton, Jack Stockdale, Nicole Eagan and Poppy Gustafsson and headquartered in Cambridge, UK, Darktrace Holdings Limited (Darktrace) offers solutions for organizations to protect their assets in the face of rising cyber-threats by applying artificial intelligence to cyber defense. The company’s technology is deployed by financial institutions, universities, museums, educational foundations, the government and defense sector, technology and telecommunication firms and the legal sector among others. The company’s Darktrace Immune System technology is used by 4700 companies to protect their digital environment, ranging from cloud and SaaS applications to IoT devices and endpoints, industrial control systems, corporate networks and asset management systems. As of 2020, the company employs over 1500 professionals across 44 offices serving over 4700 customers from 40 offices across 100 countries. In 2021, the company was listed on the London Stock Exchange along with its ticker symbol, DARK.L valuing it at USD 2.4 billion. The company’s product includes technologies that provide unsupervised machine learning to detect cyber threats. The company’s technologies provide security coverage with firewalls and various SIEMs and SOARs across major cloud services such as Microsoft 365, Zoom, Slack and Okta among others. The company offers the Darktrace Immune System platform, powered by Cyber AI self-learning technology with an open architecture to plug into a diverse ecosystem. Darktrace offers self-learning detection technology such as enterprise immune systems and industrial immune systems. Darktrace also offers automatic investigation technology such as Cyber AI Analyst that investigates breached in Darktrace, detects and illuminates suspicious activity. Additionally, the company provides autonomous response technology such as antigena networks and antigena SaaS that helps the organization to calculate and contain in-progress cyber-attacks. The company also provides cloud security, email security through antigena email and threat visualizers that help users in comprehending security incidents, metadata and event logs for investigation. The company earns revenue when organizations deploy the entire Darktrace cybersecurity platform across the entire digital business either in the cloud or in an on-premise appliance. Darktrace acquires customers through POV (Proof-of-Vision) by offering a three-week trial of the company’s products. The company earns primarily, that is 99.5% of its revenue through subscription contracts and the rest, through non-subscription contracts. The company plans to enter new geographies and sectors with its cyber AI platform. Subsequently, the company plans to increase its headcount especially in the research and development center in Cambridge, UK. ## Funding rounds - Series E, Oct 4, 2018, $50M — KKR, Vitruvian Partners, Hoxton Ventures, Ten Eleven - Series D, Jul 11, 2017, $75M — KKR, Summit Partners, Insight Partners, Ten Eleven - Series B, Jul 14, 2015, $23M — Summit Partners - Series A, Feb 27, 2015, $10M — Talis Capital, Invoke Capital, Hoxton Ventures ## Investors - Talis Capital (https://capitalatlas.ai/funds/talis-capital) — Series A - Invoke Capital (https://capitalatlas.ai/funds/invoke-capital) — Series A - Hoxton Ventures (https://capitalatlas.ai/funds/hoxton-ventures) — Series A, Series E - Summit Partners (https://capitalatlas.ai/funds/summit-partners) — Series B, Series D - KKR (https://capitalatlas.ai/funds/kkr) — Series D, Series E - Insight Partners (https://capitalatlas.ai/funds/insight-partners) — Series D - Ten Eleven — Series D, Series E - Vitruvian Partners (https://capitalatlas.ai/funds/vitruvian-partners) — Series E